Analyst Price Target is $34.67
▲ +261.11% Upside Potential
This price target is based on 5 analysts offering 12 month price targets for Tempest Therapeutics in the last 3 months. The average price target is $34.67, with a high forecast of $51.00 and a low forecast of $23.00. The average price target represents a 261.11% upside from the last price of $9.60.
Current Consensus is
The current consensus among 5 investment analysts is to buy stock in Tempest Therapeutics. This rating has held steady since July 2021, when it changed from a Hold consensus rating.